Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.84306 | 64 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.81148 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.81147 | 64 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.615 | 61 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.79393 | 64 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.9051 | 64 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.08223 | 67 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.76686 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.7566 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.79628 | 64 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.77947 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.7862 | 64 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.80896 | 63 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.09505 | 67 |